Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukaemia

British Journal of Haematology

Volumn 93, Issue 4, 1996, Pages 878-883

  Marley, S B ^a   Lewis, J L ^a   Goldman, J M ^a   Gordon, M Y ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

BFU E; CML; kinetics

Indexed keywords

ARTICLE; BURST FORMING UNIT E; CELL KINETICS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029941576     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1738.x     Document Type: Article

References (22)

1. Amos, T.A.S., Lewis, J.L., Grand, F.H., Goodong, R.P., Goldman, J.M. & Gordon, M.Y. (1995) Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation. X-irradiation and glucocorticoids. British Journal of Haematology, 91, 387-393.
2. Bedi, A., Zehnbauer, B.A., Barber, J.P., Sharkis, S.J. & Jones, R.J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038-2044.
3. Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.-M., Witte, O.N. & Baltimore, D. (1986) The chronic myelogenous leukemia-specific p210 protein is the product of the bcr-abl hybrid gene. Science, 233, 212-214.
4. Borok, R. & Preisler, H. (1994) A mathematical model of chronic myelogenous leukemia (CML), chronic phase. (Abstract). Blood, 84, (Suppl. 1), 2502.
5. Dowding, C.R., Gordon, M.Y. & Goldman, J.M. (1986) Primitive progenitor cells in the blood of patients with chronic granulocytic leukemia. International Journal of Cell Cloning, 4, 331-340.
6. Eaves, A.C. & Eaves, C.J. (1979) Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia., Experimental Hematology, 7, (Suppl. 5), 65-75.
7. Eaves, C.J. & Eaves, A.C. (1987) Cell culture studies in CML. Bailliere's Clinical Haematology, 1, 931-961.
8. Eaves, C.J., Humphries, R.K. & Eaves, A.C. (1982) In vitro characterization of erythroid precursor cells and the erythroid differentiation process. Cellular and Molecular Regulation of Hemoglobin Switching (ed. by G. Stamatoyannopoulos and A. W. Nienhuis), pp. 251-273. Grune and Stratton, New York.
9. Eaves, C., Udomsakdi, C., Cashman, J., Barnett, M. & Eaves, A. (1993) The biology of normal and neoplastic stem cells in CML. Leukemia and Lymphoma, 11, (Suppl. 1), 245-253.
10. Goldman, J.M., Shiota, F., Th'ng, K.H. & Orchard, K.H. (1980) Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia. British Journal of Haematology, 46, 7-13.
11. Gordon, M.Y. & Blackett, N.M. (1995) Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplantation, 15, 659-662.
12. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosfeld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22, Cell, 36, 93-99.
13. Gusella, J., Geller, R., Clarke, B., Weeks, W. & Houseman, D. (1976) Commitment to erythroid differentiation by Friend erythroleukemia cells: a stochastic analysis. Cell, 9, 221-229.
14. Hibbin, J.A., McCarthy, D.M. & Goldman, J.M. (1983) Antigenic expression and proliferative status of multilineage progenitor cells (CFU-gemm) in normal individuals and patients with chronic granulocytic leukaemia. Scandinavian Journal of Haematology, 31, 454-460.
15. Kurnit, D.M., Mattysse, S., Papayannopoulou, T. & Stamatoyannopoulos, G. (1985) Stochastic branching model for hemopoietic progenitor cell differentiation. Journal of Cell Physiology, 123, 55-63.
16. Marley, S.B., Amos, T.A.S. & Gordon, M.Y. (1996) Kinetics of colony formation by BFU-E grown under different culture conditions in vitro. British Journal of Haematology, 92, 559-561.
17. Paulus, J.-M., Grosdent, J.-C., Prenant, M., Fernandez-Delgado, R. & Albert. A. (1995) Factors regulating megakaryocyte progenitor commitment to polyploidization. Comptes Rendus de l'Academie de Science, Paris, 318, 779-785.
18. Roger, R., Issaad, C., Pallardy, M., Leglise, M-C., Turhan, A.G., Bartoglio, J. & Breard, J. (1996) BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood, 87, 1113-1122.
19. Singer, J.W., Adamson, J.W., Arlin, Z.A., Kempin, S., Clarkson, B.D. & Fialkow, P.J. (1981) Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy. Journal of Clinical Investigation, 67, 1593-1598.
20. Strife, A. & Clarkson, B. (1988) Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect? Seminars in Hematology, 25, 1-19.
21. Strife, A., Lambek, C., Wisniewski, D., Wachter, M., Gulati, S.C. & Clarkson, B.D. (1988) Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer Research, 48, 1035-1041.
22. Strife, A., Perez, A., Lambek, C., Wisniewski, D., Bruno, S., Darzynkiewicz, Z. & Clarkson, B. (1993) Differences in the composition and in the efficacy of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. Leukaemia Research, 17, 799-807.